Skip to main content

Table 2 Socio-demographic characterization of the patients

From: Reduced gut microbiota diversity in patients with congenital generalized lipodystrophy

 

CGL (n = 17)

Healthy (n = 17)

p value

Female; n (%)

11 (64.7)

11 (64.7)

 > 0.999

Age; years

20.0 (9.0; 31.0)

19.0 (10.0; 30)

0.823

Pre-puberty; n (%)

2 (11.8)

5 (29.4)

0.361

Adults (> 18 years-old); n (%)

9 (52.9)

9 (52.9)

 > 0.999

Urban area; n (%)

9 (52.9)

11 (64.7)

 > 0.999

Pardos; n (%)

9 (52.9)

9 (52.9)

 > 0.999

Vaginal discharge; n (%)

11 (64.7)

11 (64.7)

 > 0.999

Hospitalar discharge; n (%)

14 (82.3)

16 (94.1)

0.601

Term discharge; n (%)

16 (94.1)

17 (100)

 > 0.999

Hospital admission first 30 days of life; n (%)

3 (17.6)

0 (0)

0.227

Antibiotic use in the 30 days of life; n (%)

2 (11.8)

0 (0)

0.325

Exclusive breastfeeding time (months)

3.0 (0.5; 5.5)

5.0 (3; 6.5)

0.080

Total breastfeeding time (months)

10 (5.0; 19.5)

24 (6.0; 24.0)

0.269

BMI (kg/m2)

20.7 (18.6; 23.3)

19.0 (17.8; 27.6)

0.601

Total caloric intake (kcal)

1607 (1263; 1819)

1689 (1310; 2320)

0.357

CHO adequacy (%)

10 (58.8)

9 (52.9)

0.781

CHO intake (%)

53.7 (49.3; 56.5)

51.6 (49.0; 55.4)

0.683

Protein adequacy (%)

13 (76.5)

8 (47.1)

0.157

Protein intake (%)

23.8 (20.7; 27.2)

19.6 (17.2; 23.4)

0.048

Total fat adequacy (%)

7 (41.2)

8 (47.1)

0.092

Total fat intake (%)

20.9 (19.5; 28.2)

29.4 (25.5; 31.8)

0.024

Cholesterol (mg)

224 (193; 303)

285 (207; 448)

0.357

Fibers (g)

20.3 (15.5; 29.3)

16.9 (11.4; 28.2)

0.179

  1. Continuous variables were described using the median (25th; 75th), and categorical variables using relative and absolute frequency
  2. CGL congenital generalized lipodystrophy, CHO carbohydrate